BIOMAT Database Logo BIOMAT Database Logo

Thiadiazole derivatives: highly potent and specific HIV-1 reverse transcriptase inhibitors. 1995

Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
Tokyo Research Laboratory, Tosoh Company, Ltd., Kanagawa-ken, Japan.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
June 2009, Journal of medicinal chemistry,
Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
Specific HIV-1 reverse transcriptase inhibitors.
January 1992, Journal of enzyme inhibition,
Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
QSAR study of PETT derivatives as potent HIV-1 reverse transcriptase inhibitors.
September 2009, Journal of molecular graphics & modelling,
Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
October 2008, Bioorganic & medicinal chemistry letters,
Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase.
May 1996, Antiviral research,
Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
June 2014, European journal of medicinal chemistry,
Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.
November 2006, PLoS pathogens,
Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
April 2023, Communications chemistry,
Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
Thiadiazole derivatives: highly potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) replications in vitro.
January 1997, Microbiology and immunology,
Y Hanasaki, and H Watanabe, and K Katsuura, and H Takayama, and S Shirakawa, and K Yamaguchi, and S Sakai, and K Ijichi, and M Fujiwara, and K Konno
HIV-1 reverse transcriptase inhibitors.
June 2007, Applied microbiology and biotechnology,
Copied contents to your clipboard!